Quick answer
Kymera Therapeutics, Inc. (KYMR) reported diluted EPS of $-0.62 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-08-05. Its last four 10-Q/10-K filings were on 2026-08-05, 2026-04-30, 2026-02-26, 2025-11-04.
Data as of 2026-08-05. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Period end | Period | Form | SEC filing date | Diluted EPS |
|---|---|---|---|---|
| 2026-06-30 | Quarter | 10-Q | 2026-08-05 | $-0.62 |
| 2026-03-31 | Quarter | 10-Q | 2026-04-30 | $-0.71 |
| 2025-12-31 | Full year | 10-K | 2026-02-26 | $-3.69 |
| 2025-09-30 | Quarter | 10-Q | 2025-11-04 | $-0.94 |
| 2025-06-30 | Quarter | 10-Q | 2025-08-11 | $-0.95 |
| 2025-03-31 | Quarter | 10-Q | 2025-05-09 | $-0.82 |
| 2024-12-31 | Full year | 10-K | 2025-02-27 | $-2.98 |
| 2024-09-30 | Quarter | 10-Q | 2024-10-31 | $-0.82 |
| 2024-06-30 | Quarter | 10-Q | 2024-08-07 | $-0.58 |
| 2024-03-31 | Quarter | 10-Q | 2024-05-02 | $-0.69 |
| 2023-12-31 | Full year | 10-K | 2024-02-22 | $-2.52 |
| 2023-09-30 | Quarter | 10-Q | 2023-11-02 | $-0.90 |
| 2023-06-30 | Quarter | 10-Q | 2023-08-03 | $-0.67 |
| 2023-03-31 | Quarter | 10-Q | 2023-05-04 | $-0.70 |
| 2022-12-31 | Full year | 10-K | 2023-02-23 | $-2.87 |
| 2022-09-30 | Quarter | 10-Q | 2022-11-03 | $-0.79 |
Related
- KR earnings report dates and EPS history (Kroger Co)
- KRYS earnings report dates and EPS history (Krystal Biotech, Inc.)
- KVUE earnings report dates and EPS history (Kenvue Inc.)
- L earnings report dates and EPS history (Loews Corp)
- LAMR earnings report dates and EPS history (Lamar Advertising Co/New)
- LDOS earnings report dates and EPS history (Leidos Holdings, Inc.)
- LECO earnings report dates and EPS history (Lincoln Electric Holdings Inc)
- LEN earnings report dates and EPS history (Lennar Corp /New/)
Last updated 2026-10-16. Data only, not financial or tax advice.